After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ZNTL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Zentalis Pharmaceuticals Inc is $99.71M. A total of 0.3 million shares were traded on the day, compared to an average of 738.33K shares.
In the most recent transaction, Matrix Capital Management Comp sold 7,500,000 shares of ZNTL for 1.33 per share on Dec 15 ’25. After the transaction, the 10% Owner now owns 6,459,973 company shares. In a previous transaction on Apr 30 ’25, Myers Scott Dunseth bought 21,000 shares at 1.40 per share. ZNTL shares that Director owns now total 281,192.
Among the insiders who bought shares, Bruns Ingmar acquired of 20,000 shares on Feb 06 ’25 at a per-share price of $2.28. This resulted in the Chief Medical Officer holding 36,629 shares of ZNTL after the transaction. In another insider transaction, Cam Gallagher bought 687 shares at $2.00 per share on Feb 11 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ZNTL has a high of $3.33 and a low of $1.01.
As of this writing, ZNTL has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.25 per share and a lower estimate of -$0.53. The company reported an EPS of -$0.61 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ZNTL’s latest balance sheet shows that the firm has $339.89M in Cash & Short Term Investments as of fiscal 2021. There were $44.46M in debt and $43.94M in liabilities at the time. Its Book Value Per Share was $3.50, while its Total Shareholder’s Equity was $364.48M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZNTL is Buy with a score of 3.80.
